Close

BIO Launches New Report Profiling 100 Renewable Chemical Technology Companies

May 2 2018
BIO's new “Renewable Chemical Platforms Building the Biobased Economy” report documents the rapid expansion of renewable chemical platforms and applications around the world, profiling 100 companies from 16 countries that are commercializing renewable chemical applications.

Wisconsin Governor Walker Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

Apr 30 2018

Washington, D.C. (April 10, 2018) – The Biotechnology Innovation Organization (BIO) and BioForward Wisconsin commend...

BIO Applauds Introduction of the Opioid Addiction Action Plan Act

Apr 27 2018
Washington, DC (April 27, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the Opioid Addiction Action Plan Act, introduced yesterday in the Senate by Senators Heller (R-NV), Isakson (R-GA), and Menendez (D-NJ). A companion bill in the House, sponsored by Representatives Yvette Clarke (D-NY) and Adam Kinzinger (R-IL), was advanced by the House Energy and Commerce Health Subcommittee earlier this week.

BIO Announces Gene Editing and Synthetic Biology Programming for 2018 World Congress

Apr 27 2018
WASHINGTON, D.C. (April 26, 2018) – The Biotechnology Innovation Organization (BIO) today announced programming information for gene editing and synthetic biology at the 2018 World Congress on Industrial Biotechnology. Programming around these topics will kick off on Tuesday, July 17, with a plenary panel of experts to discuss how gene editing tools like CRISPR are revolutionizing the production of everyday products. Programming will continue with breakout sessions throughout the week, featuring executives from biotechnology companies, consumer goods producers and the government to explore the various applications for gene editing and synthetic biology in the field of industrial biotechnology.

BIO Statement on Opioid Crisis Response Act of 2018

Apr 24 2018
Washington, DC (April 24, 2018) – BIO President and CEO Jim Greenwood issued the following statement today regarding S. 2680, the Opioid Crisis Response Act of 2018:

BIO Announces Keynote and Returns to Boston June 4-7 to Celebrate 25 Years of History-Making Innovation

Apr 3 2018
TV's Robin Roberts will deliver the keynote address at the upcoming BIO International Convention which returns to Boston June 4-7. Celebrating its 25 year anniversary, BIO will host the event expected to attract more than 16,000 attendees and 1,800 exhibitors from 74 countries.

BIO Comments on DOJ’s Environmental Settlement Agreement with Philadelphia Energy Solutions

Mar 26 2018
BIO today submitted comments to the U.S. Department of Justice on the proposed Consent Decree and Environmental Settlement Agreement with the United States Bankruptcy Court for the District of Delaware in the case of Philadelphia Energy Solutions Refining and Marketing LLC and PES Holdings LLC (PES).

BIO Applauds Introduction of the Advancing Emergency Preparedness Through One Health Act of 2018

Mar 23 2018
The Biotechnology Innovation Organization (BIO) applauds the introduction of the “Advancing Emergency Preparedness Through One Health Act of 2018” by Senators Tina Smith (D-MN) and Todd Young (R-IN).

BIO Statement on Growing American Food Exports Act of 2018

Mar 23 2018
The Biotechnology Innovation Organization (BIO) today released the following statement in response to the introduction of the “Growing American Food Exports Act of 2018” by Representatives Neal Dunn (FL-02) and Jimmy Panetta (CA-20).

USDA Biobased Economy Report Indicates Potential for Rural Prosperity with Renewable Chemicals

Mar 20 2018
BIO today welcomed USDA’s release of a new report, Indicators of the U.S. Biobased Economy, which measures substantial economic growth, job creation, and household income from biofuel and bioenergy production and future growth in renewable chemicals and biobased products.